Phase 3 Failure Keeps AstraZeneca and Ionis Out of a Growing Heart Disease MarketNews DeskJuly 9, 20260 An RNA therapy from partners Ionis Pharmaceuticals and AstraZeneca failed a pivotal study as a treatment for a type of…